Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Pierre Fabre obtains good results with RSV subunit vaccine in monkey model

Sep. 24, 1998

Cangene signs WinRho distribution agreement for Australia

Sep. 24, 1998

Vertex issued first U.S. patent for IMPDH inhibitors, begins phase II trials of lead inhibitor

Sep. 23, 1998

International team reports discovery of novel immunostimulants

Sep. 21, 1998

MedImmune and Chiron enter agreement on vaccine adjuvant technology

Sep. 21, 1998

Cangene files for German approval of next-generation WinRho product

Sep. 18, 1998

DNA immunization against rabies effectively protects nonhuman primates

Sep. 17, 1998

Aviron's FluMist PLA/ELA deemed nonfilable by FDA; resubmission planned

Sep. 15, 1998

New T-cell kinase inhibitor presented by Abbott at ACS meeting

Sep. 10, 1998

Potent and selective inhibitors of p56lck kinase developed at Celltech

Sep. 9, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...